CervoMed (CRVO) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-0.84 and quarterly revenue of $117.50K.
In the most recent quarter (Q4), CervoMed reported EPS of $-0.88, missing estimates of $-0.69 by 0.28%. Revenue came in at $8.73M, exceeding the estimate of $330.00K by 25.44%.
CervoMed has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, CervoMed has averaged an EPS surprise of 0.23% and a revenue surprise of 6.63%.
Analyze the earnings history of CervoMed using advanced sorting and filters.
The chart below shows CervoMed's reported EPS compared to analyst estimates over recent quarters.
The chart below shows CervoMed's reported revenue compared to analyst estimates over recent quarters.
CervoMed (CRVO) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on March 17, 2026 for Q4.
The Actual EPS was $-0.88, which missed the estimate of $-0.69.
The Actual Revenue was $8.73M, which beat the estimate of $330.00K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-17 | $-0.88 | $-0.69 | -27.5 % |
| Q3 | 2025-11-10 | $-0.84 | $-0.61 | -37.7 % |
| Q2 | 2025-08-08 | $-0.70 | $-0.60 | -16.7 % |
| Q1 | 2025-05-12 | $-0.56 | $-0.62 | 9.68 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-17 | $8.73M | $330.00K | 2544.3 % |
| Q3 | 2025-11-10 | $322.57K | $1.14M | -71.7 % |
| Q2 | 2025-08-08 | $1.76M | $1.31M | 34.1 % |
| Q1 | 2025-05-12 | $1.92M | $1.96M | -2.17 % |